Association of Visceral Fat and Liver Fat with Hyperuricemia

Arthritis Care and Research

Volumn 68, Issue 4, 2016, Pages 553-561

  Yamada, Akiko ^a   Sato, Kyoko K ^a   Kinuhata, Shigeki ^a   Uehara, Shinichiro ^a   Endo, Ginji ^a   Hikita, Yonezo ^b   Fujimoto, Wilfred Y ^c   Boyko, Edward J ^c   Hayashi, Tomoshige ^a,c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ohtori Health Promotion Center   (Japan)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HYPERURICEMIA; INTRAABDOMINAL FAT; JAPANESE (PEOPLE); LIVER FAT; MAJOR CLINICAL STUDY; MALE; ODDS RATIO; PREVALENCE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; BLOOD; CHI SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDY; JAPAN; LIVER; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR; STATISTICAL MODEL;

ADIPOSITY; ADULT; AGED; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; HUMANS; HYPERURICEMIA; INTRA-ABDOMINAL FAT; JAPAN; LIVER; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; URIC ACID;

EID: 84961886559     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22729     Document Type: Article

References (41)

1. Roddy E, Doherty M., Epidemiology of gout. Arthritis Res Ther 2010; 12: 223.
2. Grayson PC, Kim SY, LaValley M, Choi HK., Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011; 63: 102-10.
3. Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, et al., High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PloS One 2013; 8: e56864.
4. Zhang Q, Zhang C, Song X, Lin H, Zhang D, Meng W, et al., A longitudinal cohort-based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health 2012; 12: 419.
5. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA., Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2010; 62: 170-80.
6. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA., Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum 2009; 61: 885-92.
7. Zhao G, Huang L, Song M, Song Y., Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis 2013; 231: 61-8.
8. Vague J., The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
9. Zhang ZQ, Deng J, He LP, Ling WH, Su YX, Chen YM., Comparison of various anthropometric and body fat indices in identifying cardiometabolic disturbances in Chinese men and women. PloS One 2013; 8: e70893.
10. Palmer TM, Nordestgaard BG, Benn M, Tybjaerg-Hansen A, Davey Smith G, Lawlor DA, et al., Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts. BMJ 2013; 347: f4262.
11. Hikita M, Ohno I, Mori Y, Ichida K, Yokose T, Hosoya T., Relationship between hyperuricemia and body fat distribution. Intern Med 2007; 46: 1353-8.
12. Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K., Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 1997; 46: 1162-5.
13. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al., Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51: 1979-87.
14. Liu J, Fox CS, Hickson D, Bidulescu A, Carr JJ, Taylor HA., Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study. Arterioscler Thromb Vasc Biol 2011; 31: 2715-22.
15. Koh H, Hayashi T, Sato KK, Harita N, Maeda I, Nishizawa Y, et al., Visceral adiposity, not abdominal subcutaneous fat area, is associated with high blood pressure in Japanese men: the Ohtori study. Hypertens Res 2011; 34: 565-72.
16. American Diabetes Association. Standards of medical care in diabetes, 2014. Diabetes Care 2014; 37 Suppl 1: S14-80.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
18. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al., Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-7.
19. Han TS, Kelly IE, Walsh K, Greene RM, Lean ME., Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes Relat Metab Disord 1997; 21: 1161-6.
20. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, et al., Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 2004; 80: 271-8.
21. McNeely MJ, Shofer JB, Schwartz RS, Leonetti DL, Boyko EJ, Newell-Morris L, et al., Use of computed tomography regional fat areas to estimate adiposity: correlation with hydrodensitometry, bioelectrical impedence, skinfold thickness, and body mass index [abstract]. Obes Res 1999; 7 Suppl 1: 47S.
22. Speliotes EK, Massaro JM, Hoffmann U, Foster MC, Sahani DV, Hirschhorn JN, et al., Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 2008; 23: 894-9.
23. Yamanaka H., Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids 2011; 30: 1018-29.
24. Glantz SA, Slinker BK., Multicollinearity and what to do about it: primer of applied regression & analysis of variance, 2nd edition. New York: McGraw-Hill; 2001. pp. 185-240.
25. Hilbe JM., Information criteria tests: logistic regression models. Chapman & Hall/CRC texts in statistical science series. Boca Raton: CRC Press; 2009. pp. 259-68.
26. Li Y, Xu C, Yu C, Xu L, Miao M., Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009; 50: 1029-34.
27. Lonardo A, Loria P, Leonardi F, Borsatti A, Neri P, Pulvirenti M, et al., Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease: a case-control study. Dig Liver Dis 2002; 34: 204-11.
28. Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI., Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 2013; 62: 392-9.
29. Ryu S, Chang Y, Zhang Y, Kim SG, Cho J, Son HJ, et al., A cohort study of hyperuricemia in middle-aged South Korean men. Am J Epidemiol 2012; 175: 133-43.
30. Choi YJ, Seo YK, Lee EJ, Chung YS., Quantification of visceral fat using dual-energy x-ray absorptiometry and its reliability according to the amount of visceral fat in Korean adults. J Clin Densitom 2015; 18: 192-7.
31. Xia Y, Ergun DL, Wacker WK, Wang X, Davis CE, Kaul S., Relationship between dual-energy X-ray absorptiometry volumetric assessment and X-ray computed tomography-derived single-slice measurement of visceral fat. J Clin Densitom 2014; 17: 78-83.
32. Direk K, Cecelja M, Astle W, Chowienczyk P, Spector TD, Falchi M, et al., The relationship between DXA-based and anthropometric measures of visceral fat and morbidity in women. BMC Cardiovasc Disord 2013; 13: 25.
33. Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T, et al., Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 2012; 3: 764.
34. Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY., Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes 2008; 57: 1269-75.
35. Goto T, Onuma T, Takebe K, Kral JG., The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 1995; 19: 841-5.
36. Sinn DH, Gwak GY, Park HN, Kim JE, Min YW, Kim KM, et al., Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. Am J Gastroenterol 2012; 107: 561-7.
37. Quinones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, et al., Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268: E1-5.
38. Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y, et al., Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 2009; 1: 5ra11.
39. Emmerson BT., The management of gout. N Engl J Med 1996; 334: 445-51.
40. Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, et al., Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med 2012; 44: 82-92.
41. Abe N, Honda S, Jahng D., Evaluation of waist circumference cut-off values as a marker for fatty liver among Japanese workers. Saf Health Work 2012; 3: 287-93.